Companies: 10,795·Total market cap: $144.5T

Purple Biotech Ltd.

Purple Biotech Ltd.

PPBTNASDAQHealthcare● Active

$2.92

$-0.05(-1.68%)

Market Cap$403205

P/E Ratio—

52W High$29

52W Low$2.52

Avg Volume115K

Open$2.85

Beta-0.54

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Purple Biotech Ltd.（PPBT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PPBT · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-9933.94Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding2,400Shares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 Purple Biotech Ltd. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-11080.00-24967.87%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$26.4M▼ 264.45% YoY

202320242025

FY 2025EPS$-11080.00▼ 24967.87% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$26.2MEPS: $-9933.94View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$2.92Current

$—Avg Target

$—High

合计: 2 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Purple Biotech Ltd.

$2.92-1.68%$403,205 #2

Akari Therapeutics, Plc

$15.45+2.49%$17.7M #3

CDT Equity Inc.

$0.78+0.29%$3.8M #4

Dermata Therapeutics, Inc.

$1.21+2.54%$824,684 #5

FOXO Technologies Inc.

$0.00+0.00%$2,999 #6

MSP Recovery, Inc.

$0.02-9.09%$303,037

股票表现

1D-3.37%

1W-1.71%

1M-30.51%

3M-39.96%

YTD-56.32%

1Y-89.00%

5Y-99.72%

关于 Purple Biotech Ltd.

CEOGil Efron

IPO DateNov 20, 2015

Employees9

CountryIL

Websitepurple-biotech.com

Purple Biotech Ltd. a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor im…

Biotechnology HealthcareNASDAQADRIL

关于股票概览与关键数据

Purple Biotech Ltd.（PPBT）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 20, 2015 在 NASDAQ 上市。截至最近交易日，PPBT 股价为 $2.92，市值约为 $403,205。过去12个月累计回报 -89.00%，年初至今回报 -56.32%。

根据 2 位华尔街分析师，Purple Biotech Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Purple Biotech Ltd. 营收 —，净利润 -$26.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Purple Biotech Ltd.（PPBT）股价为 $2.92，在 NASDAQ 上市，52周区间为 $2.52 – $29.00。

PPBT 最新股价PPBT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议